lamivudine has been researched along with bromodeoxyuridine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beland, FA; Bishop, ME; Dobrovolsky, VN; Hamilton, LP; Heflich, RH; Shaddock, JG; Von Tungeln, LS | 1 |
Beland, FA; Fang, JL; McGarrity, LJ | 1 |
2 other study(ies) available for lamivudine and bromodeoxyuridine
Article | Year |
---|---|
Frequency of Tk and Hprt lymphocyte mutants and bone marrow micronuclei in B6C3F(1)/Tk+/- mice treated neonatally with zidovudine and lamivudine.
Topics: Animals; Anti-HIV Agents; Bone Marrow; Bromodeoxyuridine; Drug Interactions; Drug Resistance, Neoplasm; Erythrocytes; Female; Gene Frequency; Hypoxanthine Phosphoribosyltransferase; Lamivudine; Loss of Heterozygosity; Lymphocytes; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Micronuclei, Chromosome-Defective; Mutation; Thymidine Kinase; Zidovudine | 2002 |
Interference of cell cycle progression by zidovudine and lamivudine in NIH 3T3 cells.
Topics: Animals; Blotting, Western; Bromodeoxyuridine; Cell Cycle; Cell Cycle Proteins; Cell Death; Cell Proliferation; Cell Survival; DNA; Flow Cytometry; Lamivudine; Mice; Necrosis; NIH 3T3 Cells; Zidovudine | 2009 |